A muscarinic antagonist structurally related to ATROPINE but often considered safer and more effective for inhalation use. It is used for various bronchial disorders, in rhinitis, and as an antiarrhythmic.
Ipratropium has been studied across 9 research domains including 🫁 Respiratory, 😴 Sleep, ❤️ Cardiovascular, ⚡ Energy & Fatigue, ⏳ Longevity & Aging. The primary research focus is 🫁 Respiratory with 77% of studies addressing this area.
The following compounds share molecular targets with Ipratropium, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Ipratropium is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.